Trinity Biotech buys Microtrak's product line
This article was originally published in Clinica
Executive Summary
Trinity Biotech has bought the Microtrak range of sexually transmitted disease tests from Dade Behring subsidiary Syva, for $10.2 million in cash and loan notes.